Bruce G. Allen Investments’s Catalyst Pharmaceutical CPRX Stock Holding History

Bruce G. Allen Investments’s Portfolio CPRX Stock Details CPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$966	Buy	39 +9	+30%	+$214	﹤0.01%	826
2025 Q4	$700	Buy	30 +4	+15%	+$89	﹤0.01%	901
2025 Q3	$512	Sell	26 -1	-4%	-$21	﹤0.01%	965
2025 Q2	$586	Hold	27	–	–	﹤0.01%	924
2025 Q1	$655	Hold	27	–	–	﹤0.01%	888
2024 Q4	$563	Hold	27	–	–	﹤0.01%	934
2024 Q3	$537	Buy	+27	New	+$501	﹤0.01%	942

Other funds holding CPRX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Bruce G. Allen Investments's CPRX Position: Q1 2026 in Review

Bruce G. Allen Investments increased its Catalyst Pharmaceutical (CPRX) stake by 30% in Q1 2026, buying an estimated $214 and bringing the position to 39 shares worth $966. The position accounts for ﹤0.01% of the portfolio, ranked #826.

Bruce G. Allen Investments first reported a position in CPRX in Q3 2024 and has held it in 7 quarters since. 380 funds tracked by Wall St. Rank hold CPRX as of Q1 2026.

Bruce G. Allen Investments held 39 shares of Catalyst Pharmaceutical worth $966 as of Q1 2026.
Bruce G. Allen Investments bought 9 Catalyst Pharmaceutical shares in Q1 2026, an estimated $214.
Catalyst Pharmaceutical made up ﹤0.01% of Bruce G. Allen Investments's portfolio in Q1 2026, its #826 holding.
Bruce G. Allen Investments first reported a position in Catalyst Pharmaceutical in Q3 2024 and has held it in 7 quarters since.
380 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q1 2026.

Based on Bruce G. Allen Investments's 13F filing for Q1 2026, filed 8 May 2026.